Investor Acuta Capital Partners, Llc
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Acuta Capital Partners, Llc . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2026-05-18 13D/A WHWK / Whitehawk Therapeutics, Inc. 1,921,297 4,843,775
2025-01-24 13D/A WHWK / Whitehawk Therapeutics, Inc. 1,548,081 1,921,297
2023-02-14 13G/A VTGN / Vistagen Therapeutics, Inc. 11,736,283 0
2023-02-14 13G/A JYAC / Jiya Acquisition Corp - Class A 562,500 0
2023-02-14 13G/A BLSA / BCLS Acquisition Corp - Class A 843,122 0
2022-02-15 13G/A VTGN / Vistagen Therapeutics, Inc. 12,464,974 11,736,283
2022-02-15 13G BLSA / BCLS Acquisition Corp - Class A 843,122
2022-02-15 13G/A LRMR / Larimar Therapeutics, Inc. 863,100 0
2022-02-14 13G/A CBIO / Crescent Biopharma, Inc. 1,357,500 0
2021-09-07 13D AADI / Aadi Bioscience, Inc. 1,548,081
2021-03-22 13G VTGN / Vistagen Therapeutics, Inc. 7,500,000 12,464,974
2021-02-16 13G VTGN / Vistagen Therapeutics, Inc. 7,500,000
2021-02-16 13G JYAC / Jiya Acquisition Corp - Class A 562,500
2021-02-16 13G LRMR / Larimar Therapeutics, Inc. 863,100
2021-02-16 13G CBIO / Crescent Biopharma, Inc. 0 1,357,500
2020-02-14 13G KDMN / Kadmon Holdings Inc 8,871,333 7,373,333
2019-11-13 13G IRIX / IRIDEX Corporation 0 0
2019-11-12 13G IRIX / IRIDEX Corporation 1,174,500 0
2019-02-14 13G CBIO / Crescent Biopharma, Inc. 0 0
2019-02-14 13G IOVA / Iovance Biotherapeutics, Inc. 3,019,201 3,019,201
2019-02-14 13G IRIX / IRIDEX Corporation 1,174,500 1,174,500
2019-02-14 13G KDMN / Kadmon Holdings Inc 8,871,333 8,871,333
2019-02-14 13G VCYT / Veracyte, Inc. 442,500 442,500
2019-02-14 13G ASMB / Assembly Biosciences, Inc. 1,087,104 718,500
2019-02-14 13G CASM / CAS Medical Systems, Inc. 5,160,000 5,263,508
2019-02-13 13G CBIO / Crescent Biopharma, Inc. 450,000 0
2019-02-13 13G IOVA / Iovance Biotherapeutics, Inc. 3,903,000 3,019,201
2019-02-13 13G IRIX / IRIDEX Corporation 1,612,139 1,174,500
2019-02-13 13G KDMN / Kadmon Holdings Inc 6,248,333 8,871,333
2019-02-13 13G VCYT / Veracyte, Inc. 3,295,111 442,500
2018-12-11 13G/A CEMI / Chembio Diagnostics Inc. 1,721,299 741,024
2018-12-11 13G/A IRIX / IRIDEX Corporation 2,000,000 1,612,139
2018-10-09 13G IL0011177958 / Intec Pharma Ltd 2,724,283 0
2018-02-14 13G ASMB / Assembly Biosciences, Inc. 986,599 1,087,104
2018-02-14 13G IRIX / IRIDEX Corporation 1,554,146 2,000,000
2018-02-14 13G CBIO / Crescent Biopharma, Inc. 450,000
2018-02-14 13G IL0011177958 / Intec Pharma Ltd 2,724,283 2,724,283
2018-02-14 13G IOVA / Iovance Biotherapeutics, Inc. 3,809,944 3,903,000
2018-02-14 13G CEMI / Chembio Diagnostics Inc. 1,261,171 1,721,299
2018-02-14 13G CASM / CAS Medical Systems, Inc. 4,179,838 5,160,000
2018-02-14 13G VCYT / Veracyte, Inc. 3,888,161 3,295,111
2018-02-14 13G KDMN / Kadmon Holdings Inc 6,248,333
2017-09-08 13G IL0011177958 / Intec Pharma Ltd 2,724,283
2017-08-03 13G/A IOVA / Iovance Biotherapeutics, Inc. 3,809,944 3,959,944
2017-08-03 13G/A IOVA / Iovance Biotherapeutics, Inc. 3,809,944 3,959,944
2017-08-03 13G/A ASMB / Assembly Biosciences, Inc. 976,599 986,599
2017-08-03 13G/A VCYT / Veracyte, Inc. 3,513,161 3,888,161
2017-06-12 13G CEMI / Chembio Diagnostics Inc. 1,261,171 1,261,171
2017-06-09 13G CEMI / Chembio Diagnostics Inc. 1,150,925 1,261,171
2017-02-16 13G/A IOVA / Iovance Biotherapeutics, Inc. 3,809,944 3,809,944
2017-02-16 13G/A VCYT / Veracyte, Inc. 3,513,161 3,513,161
2017-02-16 13G/A ASMB / Assembly Biosciences, Inc. 976,599 976,599
2017-02-16 13G/A CASM / CAS Medical Systems, Inc. 4,179,838 4,179,838
2017-02-16 13G/A CEMI / Chembio Diagnostics Inc. 1,150,925 1,150,925
2017-02-16 13G/A IRIX / IRIDEX Corporation 1,554,146 1,554,146
2017-02-13 13G IRIX / IRIDEX Corporation 1,011,871 1,554,146
2017-02-13 13G IOVA / Iovance Biotherapeutics, Inc. 3,809,944
2017-02-13 13G VCYT / Veracyte, Inc. 2,885,000 3,513,161
2017-02-13 13G ASMB / Assembly Biosciences, Inc. 976,599
2017-02-13 13G CASM / CAS Medical Systems, Inc. 3,200,000 4,179,838
2017-02-13 13G CEMI / Chembio Diagnostics Inc. 1,150,925
2016-07-08 13G IRIX / IRIDEX Corporation 1,011,871
2016-05-13 13G/A CBMX / CombiMatrix Corp. 711,470 47,431
2016-05-09 13G/A VCYT / Veracyte, Inc. 1,716,000 2,885,000
2016-05-09 13G/A CBMX / CombiMatrix Corp. 711,470 711,470
2016-05-09 13G/A CASM / CAS Medical Systems, Inc. 2,551,803 3,200,000
2016-02-12 13G VCYT / Veracyte, Inc. 1,716,000
2016-02-12 13G CBMX / CombiMatrix Corp. 711,470
2016-02-12 13G CASM / CAS Medical Systems, Inc. 2,551,803
2015-02-09 13G CBMX / CombiMatrix Corp. 853,278
2014-01-03 13G CBMX / CombiMatrix Corp. 501,262
2013-12-30 13G/A IDRA / Idera Pharmaceuticals, Inc. 545,385
2013-07-30 13G IDRA / Idera Pharmaceuticals, Inc.